Marks V, Samols E
J Clin Pathol. 1968 May;21(3):346-52. doi: 10.1136/jcp.21.3.346.
The capillary blood glucose response to lmg of intramuscular glucagon was determined in 13 patients with insulinoma and in 33 normal controls; the insulinoma patients showed a normal initial rise, but this was followed by an abnormally large fall, reaching hypoglycaemic levels between 90 and 180 minutes in every case. In 14 insulinoma patients the response of venous blood glucose and also plasma insulin to lmg of intravenous glucagon was compared with 10 normal controls; there was an abnormally large rise of plasma insulin in 10 of the 14 patients, and in the majority the venous blood glucose was below normal throughout the test. In these 14 patients the plasma insulin response was also determined after oral and intravenous glucose, after oral leucine, and after intravenous tolbutamide, and the value of these tests in the recognition and differential diagnosis of insulinoma was compared with that of the intravenous glucagon test.
对13例胰岛素瘤患者和33例正常对照者测定了肌内注射1毫克胰高血糖素后的毛细血管血糖反应;胰岛素瘤患者起初血糖正常升高,但随后出现异常大幅下降,在90至180分钟内均达到低血糖水平。对14例胰岛素瘤患者静脉注射1毫克胰高血糖素后的静脉血糖及血浆胰岛素反应与10例正常对照者进行了比较;14例患者中有10例血浆胰岛素出现异常大幅升高,且在大多数情况下,整个测试过程中静脉血糖均低于正常水平。对这14例患者还测定了口服和静脉注射葡萄糖后、口服亮氨酸后以及静脉注射甲苯磺丁脲后的血浆胰岛素反应,并将这些测试在胰岛素瘤识别和鉴别诊断中的价值与静脉注射胰高血糖素测试的价值进行了比较。